A biomarker‐based mathematical model to predict bone‐forming potency of human synovial and periosteal mesenchymal stem cells
Open Access
- 28 December 2007
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 58 (1), 240-250
- https://doi.org/10.1002/art.23143
Abstract
Objective To develop a biomarker-based model to predict osteogenic potency of human mesenchymal stem cells (MSCs) from synovial membrane and periosteum. Methods MSC populations were derived from adult synovium and periosteum. Phenotype analysis was performed by fluorescence-activated cell sorting and real-time reverse transcriptase–polymerase chain reaction (RT-PCR). Telomere lengths were determined by Southern blot analysis. In vitro osteogenesis was assessed quantitatively by measurements of alkaline phosphatase activity and calcium deposits. To investigate bone formation in vivo, MSCs were seeded onto osteoinductive scaffolds and implanted subcutaneously in nude mice. Bone was assessed by histology, and the human origin investigated by in situ hybridization for human Alu genomic repeats. Quantitation was achieved by histomorphometry and real-time RT-PCR for human osteocalcin. Analysis at the single-cell level was performed with clonal populations obtained by limiting dilution. Multiple regressions were used to explore the incremental predictive value of the markers. Results Periosteal MSCs had significantly greater osteogenic potency than did synovial MSCs inherent to the single cell. Bone was largely of human origin in vivo. Within the same tissue type, there was variability between different donors. To identify predictors of osteogenic potency, we measured the expression levels of osteoblast lineage genes in synovial and periosteal clonal MSCs prior to osteogenic treatment. We identified biomarkers that correlated with osteogenic outcome and developed a mathematical model based on type I collagen and osteoprotegerin expression that predicts the bone-forming potency of MSC preparations, independent of donor-related variables and tissue source. Conclusion Our findings indicate that our quality-control mathematical model estimates the bone-forming potency of MSC preparations for bone repair.Keywords
This publication has 39 references indexed in Scilit:
- Alveolar Bone Marrow as a Cell Source for Regenerative Medicine: Differences Between Alveolar and Iliac Bone Marrow Stromal CellsJournal of Bone and Mineral Research, 2005
- Embryonic stem cells and the challenge of transplantation toleranceTrends in Immunology, 2004
- Failure of in vitro–differentiated mesenchymal stem cells from the synovial membrane to form ectopic stable cartilage in vivoArthritis & Rheumatism, 2004
- Further proof of the plasticity of adult stem cells and their role in tissue repairThe Journal of cell biology, 2003
- Isolation and characterization of bone marrow multipotential mesenchymal progenitor cellsArthritis & Rheumatism, 2002
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999
- The Tetrahymena chaperonin subunit CCTη gene is coexpressed with CCTγ gene during cilia biogenesis and cell sexual reproductionFEBS Letters, 1996
- Mesenchymal stem cellsJournal of Orthopaedic Research, 1991
- Evaluation of Autologous Bone Marrow Mesenchymal Stem Cell–Calcium Phosphate Ceramic Composite for Lumbar Fusion in Rhesus Monkey Interbody Fusion ModelTissue Engineering, 1990
- Telomeres shorten during ageing of human fibroblastsNature, 1990